The association between VPS35 (VPS35 Retromer Complex Component) and Parkinson Disease 17 is well established and manually curated, with its 4 contributing sources — 3 of them expert-curated — recording a known molecular basis, pathogenic and likely-pathogenic variants, causative variation, and a susceptibility locus.
Sources4
Clinical variants161
Symptoms12
Compounds0
Trials0
Publications13
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.